30May 2016
Holy Stone Healthcare, together with representatives of Holy Stone Biotech & MDT Int’l, will be exhibiting at 2016 BIO International Convention in USA. The event will be held from June 7th – 9th at Moscone Center, San Francisco.
read more
26Feb 2016
Holy Stone Healthcare participates in the 4th Annual Biologics World Taiwan during February 25-26, 2016
read more
09Nov 2015
Holy Stone Healthcare’s IBD98-M Approved for Phase IIa Clinical Trial in Italy.
read more

Vision & Mission

We are committed to developing lifesaving therapeutics and targeted delivery technologies to improve the quality of life of patients worldwide. Our mission is to create innovative therapeutic products based on hyaluronic acid using our know-how and experience to address unmet clinical needs with superior tolerability and efficacy.


We are focused on development of new drugs and medical devices, especially hyaluronic acid related therapeutic products.